Medicare Enrolled
Dr. Hussein Shaqra, MD
Cardiovascular Disease · Clifton, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shaqra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shaqra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shaqra
Dr. Hussein Shaqra is a cardiovascular disease specialist in Clifton, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Shaqra performed 2,748 Medicare services across 1,610 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shaqra received a total of $11,043 from 48 pharmaceutical and/or device companies across 405 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shaqra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 48% volume in NJ
$11,043 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,748
Medicare services
Top 48% in NJ for cardiovascular disease
1,610
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~137 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
912 | $68 | $500 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
380 | $102 | $240 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
190 | $167 | $3,000 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
172 | $12 | $90 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
123 | $66 | $262 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
104 | $18 | $1,000 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
104 | $12 | $115 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
91 | $65 | $1,800 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
80 | $11 | $308 |
| Cardiac catheterization | 68 | $205 | $4,766 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
68 | $147 | $300 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
60 | $12 | $400 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
58 | $162 | $550 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
49 | $111 | $260 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
39 | $83 | $1,451 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
39 | $181 | $750 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
37 | $73 | $250 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
33 | $90 | $145 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
26 | $492 | $5,980 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
24 | $135 | $2,239 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
23 | $212 | $600 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $136 | $350 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
18 | $62 | $300 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
17 | $62 | $591 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
14 | $232 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.2% high complexity
18.0% medium
70.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,043
Total received (2018-2024)
Avg $1,578/year across 7 years
Top 18% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
405
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,608 (96.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$434 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,384
2023
$3,011
2022
$1,416
2021
$1,337
2020
$874
2019
$1,012
2018
$1,009
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$661
ShockWave Medical, Inc
$327
Inari Medical, Inc.
$237
AstraZeneca Pharmaceuticals LP
$218
Medtronic, Inc.
$154
Lexicon Pharmaceuticals, Inc.
$153
Actelion Pharmaceuticals US, Inc.
$139
ABIOMED
$84
Novartis Pharmaceuticals Corporation
$73
Merck Sharp & Dohme LLC
$66
Amgen Inc.
$61
PFIZER INC.
$51
HEARTFLOW, INC.
$51
Kiniksa Pharmaceuticals International, plc
$30
Bayer Healthcare Pharmaceuticals Inc.
$22
SCPHARMACEUTICALS INC.
$20
Abbott Laboratories
$18
E.R. Squibb & Sons, L.L.C.
$18
Top 3 companies account for 51.4% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,005
Abbott Laboratories
$1,430
ABIOMED
$1,073
Cardiovascular Systems Inc.
$702
Novartis Pharmaceuticals Corporation
$560
AstraZeneca Pharmaceuticals LP
$548
Amgen Inc.
$510
Merck Sharp & Dohme LLC
$348
ShockWave Medical, Inc
$347
Medtronic, Inc.
$337
Janssen Pharmaceuticals, Inc
$301
Inari Medical, Inc.
$287
Actelion Pharmaceuticals US, Inc.
$254
Medtronic Vascular, Inc.
$224
Boston Scientific Corporation
$200
Lexicon Pharmaceuticals, Inc.
$174
Kiniksa Pharmaceuticals, Ltd.
$150
Amarin Pharma Inc.
$143
Ironwood Pharmaceuticals, Inc
$141
PFIZER INC.
$114
CARDIVA MEDICAL, INC.
$94
Bolton Medical Inc
$92
Esperion Therapeutics, Inc.
$84
HeartFlow, Inc.
$79
Bayer HealthCare Pharmaceuticals Inc.
$72
E.R. Squibb & Sons, L.L.C.
$68
Merck Sharp & Dohme Corporation
$67
Bayer Healthcare Pharmaceuticals Inc.
$67
ARBOR PHARMACEUTICALS, INC.
$65
HEARTFLOW, INC.
$51
Edwards Lifesciences Corporation
$48
Regeneron Healthcare Solutions, Inc.
$43
Philips Electronics North America Corporation
$42
SCPHARMACEUTICALS INC.
$39
Acist Medical Systems, Inc.
$39
G Medical Diagnostic Services, Inc.
$31
Kiniksa Pharmaceuticals International, plc
$30
MEDICOMP INC
$30
SANOFI-AVENTIS U.S. LLC
$29
Cook Medical LLC
$17
Novo Nordisk Inc
$16
Impulse Dynamics (USA) Inc.
$16
Penumbra, Inc.
$15
EISAI INC.
$13
ARALEZ PHARMACEUTICALS US INC.
$13
Adhera Therapeutics, Inc.
$12
Althera Pharmaceuticals LLC
$12
Medicure Pharma Inc.
$11
Top 3 companies account for 40.8% of all-time payments
Associated products mentioned in payments ›
(7882) Image Guided Therapy Und · ANDEXXA · Aduhelm · Aggrastat (tirofiban HCl) · Arcalyst · BRILINTA · CAMZYOS · CARDIVA VASCADE 6/7F VCS · CHANTIX · CLOSUREFAST · COREVALVE EVOLUT R · CT THROMBECTOMY SYSTEM KIT · CVI Systems · Cardiac Monitoring Suite · Cardiva VASCADE 6/7F VCS · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DIAMONDBACK PERIPHERAL · Diamondback Coronary · Diamondback Peripheral · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FUROSCIX · HawkOne · HeartMate · Impella · Indigo System · Inpefa · JARDIANCE · JETI PERIPHERAL CATHETER · Kerendia · LEQVIO · Linzess · MITRACLIP · MULTAQ · MitraClip System · N/A · NEXLETOL · OPSUMIT · OPTIMIZER · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRESTALIA · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · RF CONTACTR · Relay Plus · Repatha · Resolute · Roszet · S · SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH THE SHOCKWAVE M5+ · STEGLATRO · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave C2+ Coronary · TELEPATCH CARDIAC MONITOR · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · XARELTO · Xience Alpine cornary stent system · ZILVER VENA · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
1,797
Per 100K population
346.7
County median income
$87,137
Nearest hospital
ST JOSEPH'S UNIVERSITY MEDICAL CENTER INC
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shaqra is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 18% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shaqra experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Shaqra performed 912 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shaqra receive payments from pharmaceutical companies?
Yes. Dr. Shaqra received a total of $11,043 from 48 companies across 405 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shaqra's costs compare to other cardiologists in Clifton?
Dr. Shaqra's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shaqra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Clifton
Browse cardiologists in Clifton ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology